简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2020-09-11 09:56 Carrier/EMSI Facilities Become First WELL Health-Safety Rated Workplaces in China
2020-09-11 09:54 Boehringer Ingelheim Advances Novel Bi-specific TRAILR2/CDH17 Antibody to Phase 1 Clinical Trial for Patients Living with Gastrointestinal Cancers
2020-09-10 16:30 Takeda Announces Results from Phase 3 Clinical Trial Evaluating NINLARO™ (ixazomib) in Newly Diagnosed Multiple Myeloma
2020-09-09 18:48 Pandemic Spotlights the Urgent Need for a National Patient Safety Board
2020-09-09 18:00 Apros Therapeutics Announces IND Clearance from U.S. FDA to Initiate the Trial of APR003, an Orally-Administered Gastrointestinal/Liver-Targeted TLR7 Agonist for Treatment of Advanced Colorectal Cancer (CRC) with Malignant Liver Lesions
2020-09-09 16:12 Invivoscribe Appoints Loui Madakamutil to Lead Its Therapeutics Division as Chief Scientific Officer
2020-09-09 10:00 Adoption of Denodo Coronavirus Data Portal Initiative Grows as More Customers and Partners Use It to Fight and Minimize the Impact of COVID-19
2020-09-09 08:36 Hong Kong Secures Multiple First-Ever MICE Events Amidst COVID-19 Challenges
2020-09-08 18:35 Takeda Divests Select Non-Core Assets in Europe to Cheplapharm for Approximately $562 million USD
2020-09-08 18:31 Fukushima SiC Applied Engineering Inc. Raises USD 30 Million (JPY 3.1 Billion) in Series C Funding
2020-09-08 13:00 Zion Pharma Announces Initiation of Phase 1 Study
2020-09-04 11:06 SpeeDx and Nepean Hospital Awarded Federal Funding for Viral Respiratory Biomarker Test
2020-09-03 10:56 Asia’s First Prescription “Digital Therapeutic” Approved in Japan; Nicotine Addiction Treatment App With CO Checker Receives Regulatory Approval - CureApp, Inc.
2020-09-02 15:11 ResMed Debuts AirTouch N20 Foam CPAP Mask, Its Softest Nasal Mask Ever
2020-09-02 14:54 Jefferies to Host Inaugural Asia Forum September 14 – 16
2020-09-02 13:30 Private Group RLS (USA) Inc. Acquires GE Healthcare’s U.S. Radiopharmacy Network
2020-09-02 13:17 Covetrus Appoints Jamey Seely General Counsel
2020-09-02 09:59 Worldwide Esports Phenomenon and Ambassador Jake Lyon to Host Unite For Safe Care Virtual Event on September 17
2020-09-01 13:29 Vifor Pharma Appoints Gregory Oakes as President North America and Member of the Executive Committee
2020-08-31 09:43 Empagliflozin reduced the combined relative risk of cardiovascular death and hospitalization for heart failure by 25 percent in adults with and without diabetes who had heart failure with reduced ejection fraction

Business Wire Weibo

Press Releases

Latest Releases